Jean‐Charles Soria

IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype

J. Cadranel, Élisabeth Quoix, Laurence Baudrin et al. · Journal of Thoracic Oncology · 2009 · 58 citations · Full text

Medicine, Oncology, Pharmacology +9

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

Guy Meyer, Benjamin Besse, H. Doubre et al. · European Respiratory Journal · 2018 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14

Association of <i>ERBB</i> Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma

Glenwood Goss, Enriqueta Felip, Manuel Cobo et al. · JAMA Oncology · 2018 · 54 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient

María Gión, Jordi Remón, Caroline Caramella et al. · Lung Cancer · 2017 · 35 citations

Medicine, Oncology, Immunotherapy +11

A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours

Antoine Hollebecque, Nadine Houédé, Ezra E.W. Cohen et al. · European Journal of Cancer · 2014 · 34 citations

Medicine, Oncology, Pharmacology +15